1
Clinical Trials associated with Autologous bone marrow mesenchymal stem cells(Apeiron Research Center) / Not yet recruitingPhase 1/2IIT Standard Optimization of Autologous Stem Cells by Intranasal and Intravenous Administration to Treat Parkinson's Disease and Atypical Parkinsonism
The purpose of this study is to measure outcomes using intranasal and intravenous autologous bone marrow mesenchymal stem cells (BM-MSCs) for Parkinson Disease (PD) and Parkinson's Plus (PPS) patients.
100 Clinical Results associated with Autologous bone marrow mesenchymal stem cells(Apeiron Research Center)
100 Translational Medicine associated with Autologous bone marrow mesenchymal stem cells(Apeiron Research Center)
100 Patents (Medical) associated with Autologous bone marrow mesenchymal stem cells(Apeiron Research Center)
100 Deals associated with Autologous bone marrow mesenchymal stem cells(Apeiron Research Center)